Chemed: Business Model, SWOT Analysis, and Competitors 2026

Chemed Corporation stands as a leading company in Healthcare. Generating $2.53 billion in annual revenue (growing -0.1% year-over-year) and carrying a market capitalization of $5.82 billion, the company has cemented its position as a foundational player in the global Medical Care Facilities landscape. Under the leadership of its leadership team, Chemed Corporation continues to execute on a multi-year strategic vision that balances growth investment with shareholder returns.

This in-depth analysis examines Chemed Corporation's business model, financial performance, competitive positioning, and SWOT analysis as of 2026. Whether you're evaluating Chemed Corporation as an investment, benchmarking it against peers, or researching its strategy, this guide covers the key factors that define Chemed Corporation's position in the Medical Care Facilities market today.

What You Will Learn

1. How Chemed Corporation generates revenue across its key business segments and the unit economics behind each
2. A data-backed SWOT analysis covering Chemed Corporation's competitive strengths, operational weaknesses, market opportunities, and external threats
3. Who Chemed Corporation's main competitors are and how the company compares on key financial metrics
4. Chemed Corporation's key financial metrics: revenue, profit margins, market cap, free cash flow, and valuation multiples
5. Chemed Corporation's strategic direction and what to watch in 2026-2027

Key Takeaways

• Revenue: $2.53 billion annual revenue (TTM), +-0.1% YoY
• Market Cap: $5.82 billion — one of the largest companies in the Healthcare sector
• Profitability: Gross margin 32.5%, operating margin 16.6%, net margin 10.5%
• Free Cash Flow: $246.01 million
• Return on Equity: 25.3% — strong
• Employees: 15,811 worldwide

Who Owns Chemed Corporation?

Chemed Corporation is publicly traded on the NYQ under the ticker symbol CHE. As a public company, it is owned by millions of shareholders ranging from retail investors to major institutional holders.

The largest shareholders of Chemed Corporation are typically major institutional investors including The Vanguard Group, BlackRock, and State Street Corporation — which collectively often hold 15-25% of publicly traded US companies. Insider ownership and the concentration of voting rights vary; investors should review the latest proxy statement filed with the SEC for precise ownership data.

Chemed Corporation has approximately 0.01 billion shares outstanding, with float shares of 0.00 billion — the freely tradeable portion. The stock trades at $412.16 per share as of early 2026.

Chemed Corporation's Mission Statement

Chemed Corporation's strategic mission is aligned with its core business activities in the Medical Care Facilities sector. The company's stated values and mission inform its capital allocation decisions, talent strategy, and long-term product roadmap. Mission statements for public companies are disclosed in annual reports and investor presentations — Chemed Corporation's most recent proxy statement and annual report are the authoritative sources for its current mission and values.

A company's mission statement matters because it signals strategic intent to employees, investors, and customers. For Chemed Corporation, the mission encompasses not just what the company does, but why it exists and how it creates value for stakeholders. Companies that maintain alignment between their stated mission and actual capital allocation decisions tend to build stronger brand trust and employee engagement over time.

In practice, Chemed Corporation's strategic priorities as communicated to investors in 2025-2026 center on revenue growth and market share expansion, profitability improvement, and sustainable returns of capital to shareholders. These operational priorities translate directly into the business model and investment thesis discussed in the following sections.

How Does Chemed Corporation Make Money?

As of 2026, Chemed Corporation generates $2.53 billion in annual revenue (growing -0.1% year-over-year), with a 32.5% gross margin and 16.6% operating margin. Market capitalization stands at $5.82 billion. Here is how the company generates its revenue:

How does Chemed Corp make money?

Chemed Corp, a diverse company, generates its revenue through two main business segments: VITAS Healthcare and Roto-Rooter. These businesses operate in distinct markets, healthcare, and plumbing services, respectively, allowing Chemed to maintain a balanced and diversified revenue stream.

VITAS Healthcare

VITAS Healthcare, a subsidiary of Chemed, is one of the largest providers of end-of-life care in the United States. It specializes in hospice care, offering services to patients with terminal illnesses. VITAS generates revenue through reimbursements from Medicare, Medicaid, and private insurance for the services it provides. These services include pain and symptom management, emotional and spiritual support, and comprehensive palliative care aimed at improving the quality of life for patients and their families. As the aging population in the U.S. increases, the demand for hospice care services also rises, contributing significantly to Chemed's income.

Roto-Rooter

Roto-Rooter, another key revenue source for Chemed, is the largest provider of plumbing and drain cleaning services in North America. This segment generates income through a wide range of services, including plumbing repairs, drain cleaning, and water restoration services, among others. Roto-Rooter serves both residential and commercial customers, offering 24/7 emergency services. Its revenue comes from direct payments from customers for the services rendered. The diverse array of services provided by Roto-Rooter, coupled with its expansive geographical footprint, ensures a consistent and reliable income stream for Chemed.

Diversification as a Strength

The diversified nature of Chemed's business operations is a significant strength, allowing the corporation to tap into different revenue streams. While VITAS Healthcare caters to the growing demand for hospice care services, Roto-Rooter captures a different market segment by offering essential plumbing services. This diversification not only stabilizes Chemed's income but also positions it for growth in multiple markets. As healthcare needs evolve and the demand for home and commercial service solutions grows, Chemed is well-placed to capitalize on these trends, driving its revenue growth further.

In conclusion, Chemed Corp makes money through its strategic operations in the healthcare and service industry sectors, leveraging the strengths of VITAS Healthcare and Roto-Rooter. Through thes

In 2026, management's strategic priorities center on operational efficiency, market share expansion, and disciplined capital allocation. Investors should review Chemed Corporation's latest annual report and quarterly earnings releases for the most current financial disclosures and strategic updates.

Chemed Corporation Business Model Canvas

The Business Model Canvas framework provides a structured view of how Chemed Corporation creates, delivers, and captures value.

Key Partners: Chemed Corporation's key partners include suppliers, distributors, technology providers, and strategic alliances that enable its core operations. In the Medical Care Facilities sector, these relationships provide supply chain resilience, expanded distribution, and access to complementary capabilities.

Key Activities: Chemed Corporation's most important activities center on product development and innovation, sales and marketing, supply chain management, customer service, and regulatory compliance. The company's ability to execute these activities at scale is a core competency.

Key Resources: Chemed Corporation's critical resources include its brand equity, intellectual property portfolio, customer relationships, human capital (15,811 employees), proprietary technology, and financial resources ($74.52M in cash).

Value Propositions: Chemed Corporation delivers value to customers through product quality, brand trust, convenience, innovation, and price competitiveness. The specific value proposition varies by customer segment but consistently addresses core needs in the Medical Care Facilities market.

Customer Relationships: Chemed Corporation maintains customer relationships through multiple channels including direct sales teams, digital platforms, customer service centers, and loyalty/membership programs. Customer retention is a key operational priority.

Channels: Chemed Corporation reaches customers through its own direct channels (stores, website, apps), third-party retailers and distributors, and partner networks. The mix of direct vs. indirect channels affects margin structure and customer data ownership.

Customer Segments: Chemed Corporation serves multiple distinct customer segments, which may include consumers, small and medium businesses, enterprise clients, and government entities — depending on its product portfolio and market positioning.

Cost Structure: Chemed Corporation's major costs include cost of goods sold (67.5% of revenue), research & development, sales & marketing, general & administrative expenses, and capital expenditures. Total operating costs represent 83.4% of revenue.

Revenue Streams: Chemed Corporation generates revenue through its core product and service offerings.

Chemed Corporation Competitors

Chemed Corporation competes against Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE), AbbVie (ABBV), Eli Lilly (LLY) and others in the Medical Care Facilities segment of the Healthcare sector.

Chemed Corporation SWOT Analysis

A SWOT analysis examines Chemed Corporation's internal strengths and weaknesses alongside external opportunities and threats.

Strengths

• Solid Profitability: Chemed Corporation maintains a gross margin of 32.5% and operating margin of 16.6%, demonstrating consistent operational execution and cost discipline in a competitive market.
• Capital Efficiency: A return on equity of 25.3% demonstrates that Chemed Corporation generates strong returns from shareholder capital, a hallmark of companies with durable competitive advantages.

Weaknesses

• Revenue Decline: Year-over-year revenue declined 0.1%, raising questions about demand for Chemed Corporation's core offerings and requiring management to articulate a credible recovery path.

Opportunities

• Total Addressable Market: Chemed Corporation operates in the Medical Care Facilities segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment translate to meaningful revenue upside, particularly as the company expands its product portfolio and geographic reach.
• International Expansion: Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Chemed Corporation's products and services.
• Strategic Acquisitions: With $74.52M in cash and strong free cash flow generation, Chemed Corporation is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

Threats

• Macroeconomic Sensitivity: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. Chemed Corporation's revenue is not fully insulated from macroeconomic cycles, and a recession scenario could meaningfully impact demand.
• Regulatory and Geopolitical Risk: Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on Chemed Corporation's business model across key markets.
• Talent Competition: Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly critical in an era of AI-driven competition.

Conclusion

Chemed Corporation enters 2026 as a leading company in Healthcare, backed by $2.53 billion in annual revenue and a 10.5% net profit margin. The company's 32.5% gross margins and $246.01 million in free cash flow provide the financial foundation to fund growth initiatives while returning capital to shareholders.

The primary opportunities ahead lie in expanding market share, operational efficiency improvements, and selective geographic expansion. The key risks to monitor include competitive pressure from established peers and new entrants, macroeconomic headwinds, and regulatory developments in Chemed Corporation's core markets.

For investors, Chemed Corporation's 22.5x trailing P/E and 15.4x forward P/E reflect the market's expectations for stable earnings. Analysts and investors should watch quarterly earnings releases, management commentary on comparable sales growth, margin trends, and capital allocation for signals of how the investment thesis is progressing.

Data Sources

Financial data and business information for this analysis was sourced from: Yahoo Finance – Chemed, SEC EDGAR – Chemed Filings, and Chemed's investor relations materials.

All financial figures reflect the most recent publicly available disclosures. Investors should verify current data before making investment decisions.

Frequently Asked Questions

1. What are 5 examples of weakness in SWOT analysis?

Chemed Corporation's primary weaknesses include: Year-over-year revenue declined 0.1%, raising questions about demand for Chemed Corporation's core offerings and requiring management to articulate a credible recovery path. These factors represent risks that investors and analysts should weigh against the company's competitive strengths.

2. What does Chemed Corporation do?

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segment

3. How much revenue does Chemed Corporation make?

Chemed Corporation generated $2.53 billion in annual revenue (TTM), with -0.1% year-over-year growth.

4. What is Chemed Corporation's market cap?

Chemed Corporation's market capitalization is approximately $5.82 billion as of early 2026.

5. Is Chemed Corporation profitable?

Yes. Chemed Corporation has a net profit margin of 10.5% and a return on equity of 25.3%.

6. Who are Chemed Corporation's competitors?

Chemed Corporation competes in the Medical Care Facilities sector against companies including Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE).

7. Does Chemed Corporation pay dividends?

Yes, Chemed Corporation pays a dividend with a current yield of approximately 56.0%.

8. What is Chemed Corporation's stock ticker?

Chemed Corporation trades on the NYQ under the ticker symbol CHE.

9. What is Chemed Corporation's P/E ratio?

Chemed Corporation's trailing P/E ratio is 22.5x and forward P/E is 15.4x, suggesting the market anticipates continued earnings growth.

10. How many employees does Chemed Corporation have?

Chemed Corporation employs approximately 15,811 people worldwide as of the most recent disclosure.